101. LSD, Nazis and the CIA with Norman Ohler

In this episode, Prof Nutt meets with German author Norman Ohler as he speaks about his new book “Tripped” which addresses drug use in post-Nazi Germany. Ohler shares how a secret history held back therapeutic research of psychedelic drugs for decades and eventually Nazi policies became part of the foundation of America’s War on Drugs.  …


100. 100 Years of the Maudsley Hospital with Dr James Rucker

  On the 100th Episode of the Drug Science podcast, Prof David Nutt meets with Dr James Rucker to celebrate the 100th anniversary of Maudsley Hospital. James shares his experiences as one of the first clinicians in a psychedelic study hosted by David Nutt before explaining his own personal journey into psychedelic research. Starting from  …


99. Anyone's Child with Anne-Marie Cockburn and Jane Slater

    In this episode, we meet with Jane Slater, co-founder of Anyone’s Child and Anne Marie, a mother who tragically lost her child, Martha, to an accidental overdose. Anne and Jane discuss the consequences of drug policy failures and the need for safe drug use education, drawing in on Anne’s personal journey. She discusses  …


98. The Merseyside Experiment with John Marks

    In this week’s episode, we feature John Marks, an Addiction Psychologist who spearheaded the Merseyside experiment in northwest England from 1982 to 1995. Throughout this 13-year period, Marks fearlessly operated clinics in Liverpool, basing his practice on the long-term maintenance prescribing of opiates to opiate users. The high media profile of his work,  …


97. 5-MeO-DMT with Patrick Cox

  In this episode, we meet with Patrick Cox, a fashion designer with a background collaborating with Vivienne Westwood. Patrick shares his personal journey from his lifestyle in fashion, led to confronting deep-seated intergenerational trauma. Patrick opens up about undertaking the highly secretive Hoffman Process, and the transformative impact this had on him. From there,  …


96. Ayahuasca: Before and After with Evgeny Lebedev

  In this episode, David Nutt meets with Evgeny Lebedev, owner of the Independent and Evening Standard newspaper. Lebedev shares his transformative journey during his first Ayahuasca ceremony in Costa Rica. Throughout the episode, Lebedev not only shares insight into the ceremony’s practices but also describes each personal ayahuasca experience and the themes that tied  …


95. Psilocybin for Obsessive-Compulsive Disorder with Sorcha O'Connor

  In the last episode of yoour live series, David meets with Sorcha as she explains her ongoing research into using low dose psilocybin in treating OCD. She discusses the pre-existing treatment paradigms for OCD and highlights the potential benefits of Psilocybin assisted psychotherapy in future treatment. She overviews her current study and the theories  …


94. Psilocybin for Sexual Wellbeing and Relationships with Tommaso Barba

  Tomasso discusses his journey on how he became interested in neuroscience and how that lead to him becoming involved with the UK’s leading Psychedelic Research Centre. He discusses the potential of psychedelics in promoting positive sexual wellbeing and healthy relationships. He discusses research into the advantages of using psilocybin as an alternative to SSRI’s  …


93. Psilocybin for Anorexia Nervosa with Hannah Douglass

  David talks to Hannah, a 3rd year PhD student as she discusses her research into using psychedelics to treat eating disorders. She highlights how following personal experiences she came to find current treatment methods for anorexia were not sufficient and instead began conducting her own research with Imperial College London to investigate psilocybin-assisted psychotherapy  …


92. Psilocybin for Gambling Addiction with Dr Rayyan Zafar

  In the first of our LIVE Psilocybin Series, David Nutt speaks to Rayyan Zafar a final year PhD student at Imperial College London.  Rayyan discusses his interest of the connection between the mind and the brain and how it led to his research into using psychedelics to treat addiction. Rayyan delves into various behavioural  …


91. The Psychedelic Industry with Josh Hardman

  In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and delves into the current state and the potential evolution of the Psychedelic industry. Psychedelic Alpha  …


90. Investing in Psychedelics with Dustin Robinson

  In this episode, Prof Jo Neill and Dr Hannah Thurgur sit down with Dustin Robinson, the visionary founding partner of Mr. Cannabis Law and a co-founder of Mr. Psychedelics Law. These law firms possess the expertise needed to navigate the intricate and strictly regulated realms of cannabis and psychedelics, addressing a wide range of  …


89. David Vs David with Dr David Erritzoe

  Recorded live from the launch event of David Nutt’s latest book, “Psychedelics: The revolutionary drugs that could change your life – a guide from the expert,” in this episode Dr. David Erritzoee and David Nutt engage in a discussion about Psychedelics. During the conversation, David Nutt provides valuable insights into the research that initially  …


88. Psychonauts with Mike Jay

  In this episode, Mike Jay explores the contents of his latest book titled “Psychonaut,” which offers a thought-provoking and unique account of the scientists, writers, artists, and philosophers who engaged in drug exploration to uncover the enigmatic realms of the mind. The podcast delves into the historical perspective of psychedelics, shedding light on the  …


87. Mental Health in Academia with Dr Meg Spriggs

  In this episode, Meg Spriggs shares her firsthand experience dealing with the challenges mental health while pursuing her studies in academia. She candidly talks about the difficulties she faced with anorexia and mood disorders which led to her investigating the potential of psilocybin for treating Anorexia Nervosa. During the discussion, Meg reveals the shame  …


86. Diamorphine Assisted Treatment with Danny Ahmed

  In this episode, Jo Neill, and Hannah Thurgur are joined by Danny Ahmed, a highly experienced Registered Mental Health Nurse and Integrated Psychotherapist with over two decades of expertise. Together, they delve into a comprehensive discussion on a variety of harm reduction techniques. Throughout the episode, Danny shares his wealth of insights into the  …


85. MDMA, Ketamine and Cannabis with Prof Valerie Curran

  In this episode, Professor Valerie Curran, discusses the psychological effects of drugs that act on the human brain. Valerie Curren holds the position of Professorial Fellow in the Neuroscience of Addiction and Mental Health Program at ACU’s Healthy Brain and Mind Research Centre. She has an esteemed background as an Emeritus Professor of Psychopharmacology  …


84. Will DMT be a medicine in the UK? with Dr Carol Routledge

Join us for an insightful episode featuring Dr. Carol Routledge, a distinguished senior scientist and the Chief Medical and Scientific Officer at Small Pharma Labs. Dr. Routledge takes us on a journey through her remarkable career path that ultimately led her to work at Small Pharma. With a wealth of experience in both preclinical and  …


83. Australia medicalises MDMA and psilocybin with Peter Hunt

  In this episode, Peter Hunt discusses the journey which led himself and his wife co-founding Mind Medicine in Australia. Mind Medicine work to alleviate the suffering and suicides caused by mental illness in Australia through expanding the treatment options available to medical practitioners and patients, particularly through the establishment of safe and effective psychedelic-assisted  …


81. Head Injury, Professional Rugby and Psychedelics with Rory Lamont

  This weeks podcast features Rory Lamont, a former professional Rugby Union player, as he discusses his experiences discovering the transformative healing potential of plant medicines such as Iboga and Ayahuasca. During the 2012 Six Nations tournament, while playing for Scotland, Rory suffered a severe leg break that brought his career to an end. Subsequently,  …


80. Cannabis for Epilepsy with Dr Evan Lewis

  In this week’s episode of the Drug Science Podcast, Prof Nutt and Dr Thurgur are joined by Dr Evan Lewis of Numinus! Dr. Evan Lewis is a Paediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), tele-neurology and medical cannabis for the treatment of neurologic disorders. He is the director  …


79. Smoking vs Vaping with Dr Alex Wodak

  In this week’s episode, join Professor David Nutt as he engages in a thought-provoking conversation with Dr Alex Wodak, an internationally renowned authority on harm reduction and the esteemed president of the Australian Drug Law Reform Foundation. With a rich background as the former director of the Alcohol and Drug Service at St Vincent’s  …


78. Are Psychedelics Anti-inflammatory? with Dr Charles Nichols

  Join us on this enlightening episode of the Drug Science podcast as we delve into the fascinating world of serotonergic pathways and their potential applications in treating psychiatric disorders and combating inflammation. Our special guest, Charles Nichols, a distinguished professor of pharmacology at LSU New Orleans, shares his groundbreaking research on the psychedelic 5-HT2A  …


77. Is Depression Evolutionary? with Dr Charles Raison

  Is depression evolutionary? Is inflammation good or bad? Can sleep be bad for you? Tune in to find out.   Depression is a complex and debilitating mental health disorder that affects millions of people worldwide. Despite the prevalence of depression, its causes and origins are still not entirely understood. In this episode of the  …


76. What is Decriminalisation? with Kassandra Frederique

  Are you curious about the impact of drug policies on marginalized communities? Then tune in to this week’s episode of our podcast! Our guest, Kassandra Frederique, the Executive Director of the Drug Policy Alliance, joins Dr. Hannah Thurgur to discuss the impact of drug policies on Black, Latino, Indigenous, immigrant, and LGBTQ communities. You’ll  …


T21 - Medical Cannabis bonus episode

  T21 (formerly Project Twenty21) is a pioneering medical cannabis registry launched in the United Kingdom in 2019. It aims to create the UK’s largest body of evidence for the effectiveness and tolerability of medical cannabis in treating a range of conditions. T21 focuses on patients with conditions that can be treated with medical cannabis  …


75. DMT for Depression with Dr Graham Campbell

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week’s episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field. Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his  …


74. Welcome to Season 4 with Dr Thurgur and Prof Neill

  Welcome to season 4 of the Drug Science Podcast! In this episode, we’re introducing our new hosts: Professor Jo Neill and Dr Hannah Thurgur! Jo Neill is a professor of psychopharmacology at the University of Manchester and the chair of the Medical Psychedelics Working Group of Drug Science. Following years of clinical and scientific  …


Drug Science Live - Part 2

  This week we present you with part 2 of the podcast recorded live at the book launch of ‚Drug Science and British Drug Policy’. We’re going to hear panel discussions on the Misuse of Drugs Act 1971 and different approaches to drug policy with co-authors of the book. This time, professor David Nutt will  …


Drug Science Live - Part 1

  This week we present you with a podcast recorded live at the book launch of ‚Drug Science and British drug policy’. We’re going to hear panel discussions on the Misuse of Drugs Act 1971 and different approaches to drug policy with co-authors of the book. In part 1 professor David Nutt will talk with  …